company background image
RXMD logo

Progressive Care OTCPK:RXMD Stock Report

Last Price

US$1.85

Market Cap

US$11.9m

7D

-2.6%

1Y

-43.9%

Updated

17 Apr, 2024

Data

Company Financials

Progressive Care, Inc.

OTCPK:RXMD Stock Report

Market Cap: US$11.9m

Progressive Care, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Progressive Care
Historical stock prices
Current Share PriceUS$1.85
52 Week HighUS$6.05
52 Week LowUS$0.40
Beta-0.25
1 Month Change-21.28%
3 Month Change-37.31%
1 Year Change-43.94%
3 Year Change-90.70%
5 Year Change-84.96%
Change since IPO-92.29%

Recent News & Updates

Recent updates

Shareholder Returns

RXMDUS Consumer RetailingUS Market
7D-2.6%-2.0%-3.7%
1Y-43.9%15.1%20.5%

Return vs Industry: RXMD underperformed the US Consumer Retailing industry which returned 16.1% over the past year.

Return vs Market: RXMD underperformed the US Market which returned 20.2% over the past year.

Price Volatility

Is RXMD's price volatile compared to industry and market?
RXMD volatility
RXMD Average Weekly Movement18.0%
Consumer Retailing Industry Average Movement4.6%
Market Average Movement6.0%
10% most volatile stocks in US Market16.4%
10% least volatile stocks in US Market3.0%

Stable Share Price: RXMD's share price has been volatile over the past 3 months.

Volatility Over Time: RXMD's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a143Charles Fernandezprogressivecareus.com

Progressive Care, Inc. operates as a healthcare services and technology company in south Florida. The company provides prescription pharmaceuticals; COVID-19 related diagnostics and vaccinations; compounded medications; tele-pharmacy services; anti-retroviral medications; medication therapy management; and medication adherence packaging and contracted pharmacy services. It also supplies various prescription medications to long term care facilities.

Progressive Care, Inc. Fundamentals Summary

How do Progressive Care's earnings and revenue compare to its market cap?
RXMD fundamental statistics
Market capUS$11.86m
Earnings (TTM)-US$14.65m
Revenue (TTM)US$49.73m

0.2x

P/S Ratio

-0.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RXMD income statement (TTM)
RevenueUS$49.73m
Cost of RevenueUS$34.57m
Gross ProfitUS$15.16m
Other ExpensesUS$29.81m
Earnings-US$14.65m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-2.35
Gross Margin30.49%
Net Profit Margin-29.46%
Debt/Equity Ratio4.7%

How did RXMD perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.